CLCA2_Clac2 Activators belong to a class of molecules that play a pivotal role in ion transport regulation within various physiological contexts. These activators specifically target the CLCA2 (Calcium-activated chloride channel regulator 2) or Clac2 protein, which is a member of the calcium-activated chloride channel regulator family. The primary function of CLCA2_Clac2 Activators is to modulate the activity of CLCA2, thereby influencing chloride ion flux across cell membranes. This family of activators is characterized by its ability to bind to CLCA2 and enhance its chloride channel regulatory function. CLCA2_Clac2 Activators act as allosteric modulators, binding to specific sites on the CLCA2 protein to induce conformational changes that promote its chloride channel activity.
By doing so, they regulate the movement of chloride ions across cell membranes, which is crucial for maintaining proper ion homeostasis in various tissues. This ion transport regulation is essential for normal physiological processes, including the control of mucus secretion in the respiratory system and electrolyte balance in the digestive tract. While the focus here is on their molecular mechanism and structural interactions, it's important to note that CLCA2_Clac2 Activators have garnered attention for their roles in various diseases. In summary, CLCA2_Clac2 Activators represent a class of molecules that act as regulators of the CLCA2 protein, fine-tuning its chloride channel activity to maintain proper ion transport in different tissues.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid has been shown to regulate gene expression via the retinoic acid receptor, potentially affecting the expression of CLCA2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an adenylate cyclase activator which could upregulate CLCA2 through cAMP-mediated pathways. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a synthetic glucocorticoid, may affect CLCA2 expression via the glucocorticoid receptor. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound is a DNA methyltransferase inhibitor and could potentially induce CLCA2 expression by altering gene methylation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate is a histone deacetylase inhibitor and might upregulate CLCA2 by modifying chromatin structure. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen is an estrogen receptor modulator and could affect the expression of CLCA2 through hormone-related pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known for its anti-inflammatory properties and may upregulate CLCA2 expression via the NF-κB pathway. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin may induce the expression of CLCA2 via its role in DNA intercalation and gene expression modulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is another histone deacetylase inhibitor and might play a role in the upregulation of CLCA2 by modifying chromatin structure. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid is also a histone deacetylase inhibitor and could upregulate CLCA2 through similar epigenetic mechanisms. | ||||||